Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 415, 462 (31 January 2002) | doi:10.1038/415462a
Nerve inflammation halts trial for Alzheimer's drug
Erika Check
Trials of a new immunotherapy drug for Alzheimer's disease have hit a roadblock, with four of the participants developing potentially serious problems in the nervous system. Some researchers say the side-effect could have been anticipated before the trial began.
To read this story in full you will need to login or make a payment (see right).
